{"id":384418,"date":"2020-11-18T16:08:24","date_gmt":"2020-11-18T21:08:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=384418"},"modified":"2020-11-18T16:08:24","modified_gmt":"2020-11-18T21:08:24","slug":"exagen-inc-to-participate-in-december-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/","title":{"rendered":"Exagen Inc. to Participate in December Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN DIEGO, Nov.  18, 2020  (GLOBE NEWSWIRE) &#8212; Exagen Inc.\u00a0(Nasdaq: XGN),\u00a0an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following December investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:6pt\">\n          <strong>Piper Sandler 32<\/strong><br \/>\n          <sup><br \/>\n            <strong>nd<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Virtual Healthcare Conference, November 30 \u2013 December 3, 2020<br \/><\/strong>A recorded company presentation will be available via the Piper Sandler conference site from November 23 to December 3, and on the Exagen website at: <a href=\"https:\/\/investors.exagen.com\/events\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/investors.exagen.com\/events<\/a><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Evercore<\/strong><br \/>\n          <strong> ISI 3<\/strong><br \/>\n          <sup><br \/>\n            <strong>rd<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual <\/strong><br \/>\n          <strong>HealthCONx<\/strong><br \/>\n          <strong> Conference, December 1-3, 2020<br \/><\/strong>Exagen President and CEO Ron Rocca will participate in a Fireside Chat on Wednesday, December 2, 2020, at 10:30 am EST. A link to the live webcast of the Fireside Chat will be posted to the Exagen website at: <a href=\"https:\/\/investors.exagen.com\/events\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/investors.exagen.com\/events<\/a><\/li>\n<\/ul>\n<p align=\"left\">\n        <strong>About\u00a0Exagen Inc.<\/strong>\n      <\/p>\n<p align=\"left\">Exagen\u00a0is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention.\u00a0Exagen\u00a0has developed and is commercializing a portfolio of innovative testing products under its AVISE\u00ae brand. Several of these products are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. CB-CAPs assess the activation of the complement system, a biological pathway implicated in systemic lupus erythematosus, or SLE. Exagen\u2019s goal is to enable rheumatologists to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including SLE and rheumatoid arthritis, or RA. Exagen\u2019s model of integrating testing products and therapeutics positions\u00a0Exagen\u00a0to offer targeted solutions to rheumatologists and, ultimately, better serve patients.\u00a0 For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iVlCr-kR87OHvi5hOZ9g6lah-Y2jEhE_g0WwcJzoJH4jkJgTe1bxANyHgNyFCRZg0__fqK6weoR2g9ebOrckVg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.Exagen.com<\/u><\/a>.<\/p>\n<p align=\"left\">\n        <strong>Investors<\/strong><br \/>\n        <br \/>Westwicke Partners<br \/>Mike Cavanaugh<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iw67NunWHKWPRDM6tEeoA4dAcyuMCMFx12gR8NjEtzPW3gzBvOFXGxa88rNhZXppOIMmtzos1ZFGH1vdPR5zwEIsxEVnoj5uynFeMeP5v_hBAaDdB74zPmEHQi7YKI6I\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Mike.Cavanaugh@westwicke.com<\/u><\/a>\u00a0<br \/>646.677.1838<\/p>\n<p align=\"left\">\n        <strong>Company<\/strong><br \/>\n        <br \/>Exagen Inc.<br \/>Kamal Adawi, Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YdAvAkftciZItNo9apQXnEhm9CuCn897aIv6pEpyIA73YtwTzfWur6e67s2V5t-i5UEcN7s8UlOc0oF5T2j3LQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>kadawi@exagen.com<\/u><\/a><br \/>760.477.5514<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/e02da419-bf68-433e-af2b-be8c6d47d13a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Nov. 18, 2020 (GLOBE NEWSWIRE) &#8212; Exagen Inc.\u00a0(Nasdaq: XGN),\u00a0an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following December investor conferences: Piper Sandler 32 nd Annual Virtual Healthcare Conference, November 30 \u2013 December 3, 2020A recorded company presentation will be available via the Piper Sandler conference site from November 23 to December 3, and on the Exagen website at: https:\/\/investors.exagen.com\/events Evercore ISI 3 rd Annual HealthCONx Conference, December 1-3, 2020Exagen President and CEO Ron Rocca will participate in a Fireside Chat on Wednesday, December 2, 2020, at 10:30 am EST. A link to the live webcast of the Fireside Chat will be posted to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Exagen Inc. to Participate in December Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-384418","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exagen Inc. to Participate in December Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exagen Inc. to Participate in December Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Nov. 18, 2020 (GLOBE NEWSWIRE) &#8212; Exagen Inc.\u00a0(Nasdaq: XGN),\u00a0an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following December investor conferences: Piper Sandler 32 nd Annual Virtual Healthcare Conference, November 30 \u2013 December 3, 2020A recorded company presentation will be available via the Piper Sandler conference site from November 23 to December 3, and on the Exagen website at: https:\/\/investors.exagen.com\/events Evercore ISI 3 rd Annual HealthCONx Conference, December 1-3, 2020Exagen President and CEO Ron Rocca will participate in a Fireside Chat on Wednesday, December 2, 2020, at 10:30 am EST. A link to the live webcast of the Fireside Chat will be posted to &hellip; Continue reading &quot;Exagen Inc. to Participate in December Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-18T21:08:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Exagen Inc. to Participate in December Investor Conferences\",\"datePublished\":\"2020-11-18T21:08:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/\"},\"wordCount\":291,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/\",\"name\":\"Exagen Inc. to Participate in December Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=\",\"datePublished\":\"2020-11-18T21:08:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-participate-in-december-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exagen Inc. to Participate in December Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exagen Inc. to Participate in December Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Exagen Inc. to Participate in December Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, Nov. 18, 2020 (GLOBE NEWSWIRE) &#8212; Exagen Inc.\u00a0(Nasdaq: XGN),\u00a0an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following December investor conferences: Piper Sandler 32 nd Annual Virtual Healthcare Conference, November 30 \u2013 December 3, 2020A recorded company presentation will be available via the Piper Sandler conference site from November 23 to December 3, and on the Exagen website at: https:\/\/investors.exagen.com\/events Evercore ISI 3 rd Annual HealthCONx Conference, December 1-3, 2020Exagen President and CEO Ron Rocca will participate in a Fireside Chat on Wednesday, December 2, 2020, at 10:30 am EST. A link to the live webcast of the Fireside Chat will be posted to &hellip; Continue reading \"Exagen Inc. to Participate in December Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-18T21:08:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Exagen Inc. to Participate in December Investor Conferences","datePublished":"2020-11-18T21:08:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/"},"wordCount":291,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/","name":"Exagen Inc. to Participate in December Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=","datePublished":"2020-11-18T21:08:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODcwMCMzODM0MzQyIzIwMTA5NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-participate-in-december-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Exagen Inc. to Participate in December Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=384418"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384418\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=384418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=384418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=384418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}